// App-Quantinova.ai

3932 : Long-Lasting Responses with Lenalidomide As Initial Therapy of Elderly Patients with Chronic Lymphocytic Leukemia (CLL)

Researchers

Presenter

  • Michael J. Keating

Principal Investigators

  • William G. Wierda

  • Xavier C. Badoux

  • Steliana Calin

  • James M. Reuben

  • Susan M. O'Brien

  • Steven M. Kornblau

  • Hagop M. Kantarjian

  • Bang-Ning Lee

  • Alessandra Ferrajoli

Medical Centers

  • Lymphoma, St. George Hospital Cancer Care Centre, Kogarah, Australia,

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Cutaneous squamous cell carcinoma

  • Chronic Lymphocytic Leukemia

  • Immune thrombocytopenia

  • Squamous cell carcinoma

  • Deep vein thrombosis

  • Basal cell carcinoma

  • Peripheral neuropathy

  • Venous thrombosis

  • Thrombocytopenia

  • Neutropenia

  • Solid malignancies

  • Sepsis

Biomarkers

  • Cluster of Differentiation 2AP

  • C-X-C motif chemokine ligand 8

  • Interleukin 6

Drug/Treatment

  • Lenalidomide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved